• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Orexo AB (ORX)

1
Sell: 38.85 SEK|Buy: 39.45 SEK|Change: 0.95 (2.49%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Address

P.O. Box 303 Virdings alle 32 A
Uppsala
SWE
751 05

Telephone

+46 187808800

Website

https://www.orexo.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Orexo AB Third Quarter Earnings Results for 20262026-10-23T08:00:00
Orexo AB Third Quarter Earnings Conference Call for 20262026-10-23T00:00:00
Orexo AB Second Quarter Earnings Conference Call for 20262026-07-16T14:00:00
Orexo AB Second Quarter Earnings Results for 20262026-07-16T08:00:00
Orexo AB Annual General Meeting for 20262026-05-08T16:00:00
Orexo AB First Quarter Earnings Conference Call for 20262026-05-06T14:00:00
Orexo AB First Quarter Earnings Results for 20262026-05-06T00:00:00
Orexo AB Annual Report for 20252026-03-27T00:00:00
Orexo AB Fourth Quarter Earnings Results for 20252026-02-05T08:00:00
Orexo AB Fourth Quarter Earnings Conference Call for 20252026-02-05T00:00:00
Orexo AB Third Quarter Earnings Results for 20252025-10-23T08:00:00
Orexo AB Third Quarter Earnings Conference Call for 20252025-10-23T00:00:00

Previous key dates

NameKey Date
Orexo AB Third Quarter Earnings Results for 20252025-10-23T08:00:00
Orexo AB Third Quarter Earnings Conference Call for 20252025-10-23T00:00:00
Orexo AB Second Quarter Earnings Conference Call for 20252025-07-16T14:00:00
Orexo AB Second Quarter Earnings Results for 20252025-07-16T08:00:00
Orexo AB Annual General Meeting for 20252025-05-08T16:00:00
Orexo AB First Quarter Earnings Conference Call for 20252025-05-06T14:00:00
Orexo AB First Quarter Earnings Result for 20252025-05-06T00:00:00
Orexo AB Annual Report for 20242025-03-28T00:00:00
Orexo AB Fourth Quarter Earnings Conference Call for 20242025-02-06T14:00:00
Orexo AB Fourth Quarter Earnings Results for 20242025-02-06T08:00:00
Orexo AB Third Quarter Earnings Conference Call for 20242024-10-24T14:00:00
Orexo AB Third Quarter Earnings Results for 20242024-10-24T08:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.